Sutton Wealth Advisors Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sutton Wealth Advisors Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q1 2023$4,876
-97.2%
53
-97.3%
0.00%
-95.5%
Q4 2022$175,543
+19.4%
1,9350.0%0.07%
+11.7%
Q3 2022$147,079
+82.8%
1,935
+103.3%
0.06%
+87.5%
Q2 2022$80,473
+81.2%
952
+88.1%
0.03%
+113.3%
Q1 2022$44,402
+857.8%
506
+854.7%
0.02%
+650.0%
Q4 2021$4,636
+7.0%
530.0%0.00%0.0%
Q3 2021$4,334
-10.4%
530.0%0.00%0.0%
Q2 2021$4,836
+6.8%
530.0%0.00%0.0%
Q1 2021$4,530
-9.5%
530.0%0.00%0.0%
Q4 2020$5,005
+8.6%
530.0%0.00%0.0%
Q3 2020$4,609
-0.4%
530.0%0.00%0.0%
Q2 2020$4,629
+5.9%
530.0%0.00%
-33.3%
Q1 2020$4,370
-12.9%
530.0%0.00%0.0%
Q4 2019$5,019
+9.0%
530.0%0.00%0.0%
Q3 2019$4,606
-4.8%
530.0%0.00%0.0%
Q2 2019$4,839
-5.0%
530.0%0.00%0.0%
Q1 2019$5,095
+12.0%
530.0%0.00%0.0%
Q4 2018$4,548
-0.4%
530.0%0.00%0.0%
Q3 2018$4,566
+14.0%
530.0%0.00%0.0%
Q2 2018$4,004
-6.6%
530.0%0.00%0.0%
Q1 2018$4,285
-3.7%
530.0%0.00%0.0%
Q4 2017$4,450
-2.2%
530.0%0.00%0.0%
Q3 2017$4,550
+2.8%
530.0%0.00%
-25.0%
Q2 2017$4,424
+12.4%
530.0%0.00%
+33.3%
Q1 2017$3,936
+1.9%
530.0%0.00%0.0%
Q4 2016$3,861
-7.7%
530.0%0.00%
-25.0%
Q3 2016$4,185
-4.3%
530.0%0.00%0.0%
Q2 2016$4,373
-85.0%
53
-86.8%
0.00%
-85.7%
Q1 2016$29,1934030.03%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders